Cannabis
ZYUS – SUCCESS PAGE – December 19, 2024
ZYUS Life Sciences (CVE: ZYUS) is creating a world where chronic pain is managed effectively, safely, and compassionately.
ZYUS Life Sciences (CVE: ZYUS) is creating a world where chronic pain is managed effectively, safely, and compassionately.
Developing drugs aimed at the central nervous system to treat neurological disorders including Alzheimer’s, chronic pain, and obesity
Direct Biologics is a clinical-stage biotech innovator that is harnessing signaling molecules to reduce overactive inflammatory response
Ceresti’s Caregiver-Enabled Dementia Program is a tech-powered approach to dementia care that reduces the total cost of care by more than 30%
A biotech company developing a platform of novel antibodies and ADCs to treat life-threatening cancers including leukemia and lymphoma
A clinical-stage precision medicine company enhancing patient outcomes through improved decision-making and personalized cancer care.
An innovative, clinical stage, drug development company that is creating a potential novel treatment for degenerative eye disease
ZYUS Life Sciences (CVE: ZYUS) is creating a world where chronic pain is managed effectively, safely, and compassionately.
Developing drugs aimed at the central nervous system to treat neurological disorders including Alzheimer’s, chronic pain, and obesity
Direct Biologics is a clinical-stage biotech innovator that is harnessing signaling molecules to reduce overactive inflammatory response
Ceresti’s Caregiver-Enabled Dementia Program is a tech-powered approach to dementia care that reduces the total cost of care by more than 30%
A biotech company developing a platform of novel antibodies and ADCs to treat life-threatening cancers including leukemia and lymphoma
1460 Broadway
New York, NY 10036
(917) 747-6198
© Copyright 2025 FORCE Family Office
